Scientist Arjan Griffioen leads cancer treatment innovation with lab and startup (Amsterdam UMC)
Could an innovative cancer treatment be used as a preventative vaccine? Arjan Griffioen and his team are determined to find out. These scientists have been developing proteins that specifically target cancer cells in the blood, leaving healthy tissue untouched. Every step of this journey—from vision to execution—has relied on the team’s dedication, as well as essential funding and investment. Spoiler alert: bringing the new treatment to market is not done overnight! Curious about the steps necessary? Watch the video to hear the full story by Arjan Griffioen and Else Huijbers.
Explore other Stories:
Biobanks crucial for novel diagnostics or therapeutics
Biobanks contain valuable information on the donor of the sample. Access to these collections can be crucial for companies developing novel diagnostics or therapeutics.
Patenting: steps to bring innovation to the clinic
To make innovations in health care quickly accessible for patients, it is vital to assign value and significance to inventions (=valorization). One way to valorize is to protect the novel intellectual property by a patent. The patent underlines the importance of the finding and grants value, which is necessary for clinical development and implementation. Have […]
Less pain, more scientific value
When Ard den Heeten, professor of Radiology teamed up with his AMC colleague Kees Grimbergen, professor of Medical Technology, a new approach to mammography was born. It has been developed upon Grimbergen’s observation of a serious flaw in the current mammogram procedure: the establishment of a standard force of the so-called “paddle” compressing the breasts. […]